ID

29792

Descripción

Study ID: 101464 Clinical Study ID: SCA101464 Study Title: A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of a Flexible Dose of Lamotrigine Compared to Placebo as an Adjunctive Therapy to an Atypical Antipsychotic Agent(s) in Subjects with Schizophrenia Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00086593 https://clinicaltrials.gov/ct2/show/NCT00086593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: lamotrigine Study Indication: Lamictal XR,Lamictal,LAMICTIN This ODM form contains Concomitant Medications.

Link

https://clinicaltrials.gov/ct2/show/NCT00086593

Palabras clave

Versiones (1)
  1. 19/4/18 19/4/18 - Sarah Riepenhausen
Titular de derechos de autor

GlaxoSmithKline

Subido en

19 de abril de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Evaluation of a Flexible Dose of Lamotrigine Compared to Placebo as an Adjunctive to Atypical Antipsychotic Agents in Schizophrenia NCT00086593

Inglés

Concomitant Medications

1 formularios  
Concomitant Medications
Descripción

Concomitant Medications

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject during the study?
Descripción

If Yes, complete the other Items of this Itemgroup.

Tipo de datos

text

Alias
UMLS CUI [1]
C2347852
Drug Name
Descripción

Record over-the-counter and prescription drugs prescribed. Trade names are preferred for all medications; this is particularly encouraged for all combination medications, e.g., multivitamins and cold medications. The subject should be encouraged to disclose all medications he/she is taking, including non-prescribed medications, herbal remedies, and nutritional supplements. If the subject is female, cross-check with the DEMOGRAPHY FOR FEMALES page that any contraceptive drugs taken by the subject are recorded.

Tipo de datos

text

Alias
UMLS CUI [1]
C2360065
Dose
Descripción

Dose

Tipo de datos

float

Alias
UMLS CUI [1]
C3174092
Units
Descripción

Units

Tipo de datos

text

Alias
UMLS CUI [1]
C2826646
Frequency
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C2826654
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C2826730
Date Started
Descripción

If the concomitant medication start date is prior to the study start date, affirm ‘Was medication started pre-study?’.

Tipo de datos

date

Alias
UMLS CUI [1]
C2826734
Was medication started pre-study?
Descripción

If a concomitant medication was started pre-study, check that the indication is recorded on the CURRENT MEDICAL CONDITIONS page.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2981448
Date stopped
Descripción

Record the stop date if concomitant medication is stopped prior to the end of the study. If the subject is to continue taking the concomitant medication after the study is over, affirm ‘Was medication continued post-study?’.

Tipo de datos

date

Alias
UMLS CUI [1]
C2826744
Was medication continued post-study?
Descripción

Ongoing Medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826666
Conditions treated / Indication
Descripción

Conditions treated / Indication

Tipo de datos

text

Alias
UMLS CUI [1]
C2826696
Prophylaxis?
Descripción

Prophylaxis

Tipo de datos

text

Alias
UMLS CUI [1]
C0199176
Was drug administered for an adverse event?
Descripción

If the concomitant medication was taken for an adverse event, check that the event is entered on the appropriate ADVERSE EVENTS page(s) and that the dates are consistent with the event.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C2347852
Was drug administered as a rescue medication?
Descripción

Rescue medication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0884980
Volver a la parte superior de la página

Similar models

Concomitant Medications

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Concomitant Medications
C2347852 (UMLS CUI-1)
Item
Were any concomitant medications taken by the subject during the study?
text
C2347852 (UMLS CUI [1])
Concomitant Medications
Code List
Were any concomitant medications taken by the subject during the study?
CL Item
Yes (Y)
CL Item
No (N)
Drug Name
Item
Drug Name
text
C2360065 (UMLS CUI [1])
Dose
Item
Dose
float
C3174092 (UMLS CUI [1])
Units
Item
Units
text
C2826646 (UMLS CUI [1])
Frequency
Item
Frequency
text
C2826654 (UMLS CUI [1])
Route
Item
Route
text
C2826730 (UMLS CUI [1])
Date Started
Item
Date Started
date
C2826734 (UMLS CUI [1])
Pre-study start
Item
Was medication started pre-study?
boolean
C2981448 (UMLS CUI [1])
Date stopped
Item
Date stopped
date
C2826744 (UMLS CUI [1])
Ongoing Medication
Item
Was medication continued post-study?
boolean
C2826666 (UMLS CUI [1])
Conditions treated / Indication
Item
Conditions treated / Indication
text
C2826696 (UMLS CUI [1])
Item
Prophylaxis?
text
C0199176 (UMLS CUI [1])
Prophylaxis
Code List
Prophylaxis?
CL Item
yes (Y)
CL Item
no (N)
Item
Was drug administered for an adverse event?
text
C0877248 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Concomitant Medications
Code List
Was drug administered for an adverse event?
CL Item
Yes (Y)
CL Item
No (N)
Item
Was drug administered as a rescue medication?
text
C0013227 (UMLS CUI [1,1])
C0884980 (UMLS CUI [1,2])
Concomitant Medications
Code List
Was drug administered as a rescue medication?
CL Item
Yes (Y)
CL Item
No (N)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial